# Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study

> **NCT02471053** · NA · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 12 (actual)

## Conditions studied

- Neoplasms
- Heart; Disease, Functional
- Inflammation

## Interventions

- **OTHER:** Moderate Intensity Exercise

## Key facts

- **NCT ID:** NCT02471053
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471053, "Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02471053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*